Important note: Information in this article was accurate in 2005. The state of the art may have changed since the publication date.
Important note: Information in this article was accurate in 2005. The state of the art may have changed since the publication date.
Reuters NewMedia - November 30, 2005
Allyn Fisher-Ilan
Dr. Robert Gallo, the director of the University of Maryland's Institute for Human Virology, said results from animal studies were encouraging.
"I think we've made some advances in making antibodies that will react with the variety of strains of HIV," he told Reuters, referring to the virus that causes AIDS.
Scientists believe a vaccine is the best hope for ending the global AIDS pandemic that has killed about 3.1 million people this year. But defeating the virus has proved more difficult than researchers had expected.
Gallo, in Israel to accept an award from Bar-Ilan University in advance of World AIDS day on Thursday, said it was still too early to say when a vaccine could be produced for humans.
Researchers believe an effective AIDS vaccine is still many years away.
"We have had some interesting results in the monkeys that show we can make an immune response,," Gallo said, noting potential progress on overcoming the problem of mutation of the virus.
But the antibodies produced in his experiments lasted only up to four months, which is far less than needed for an effective vaccine.
"We are making progress with a preventive vaccine, but we are not there yet," added Gallo, who discovered the AIDS virus with France's Luc Montagnier.
Earlier this week Europe's biggest drug maker GlaxoSmithKline Plc announced a plan to develop an experimental AIDS vaccine along with France's Institut Pasteur.
They intend to make the vaccine by fusing genes from HIV on to an existing vaccine for measles.
More than 30 AIDS vaccine trials in humans are ongoing but no one can predict if any will be effective against the virus that has infected nearly 5 million people in 2005.
Antiretroviral drugs have prolonged lives of people with HIV/AIDS but public health experts say preventing the spread of virus, by using condoms, abstinence and needle exchange programs, is also essential for halting the epidemic.
The number of people living with HIV/AIDS hit a record high of 40.3 million this year, according to the latest figures from the Joint United Nations Program on HIV/AIDS (UNAIDS) and the World Health Organization.
051130
RE051143
Copyright © 2005 - Reuters, Ltd. All rights reserved. Republication or redistribution of Reuters content is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Contact Reuters.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2005. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2005. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .